4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
CDT Equity Inc. (CDT) operates in the Biotechnology industry and is headquartered in Naples, United States with about 4 employees. Its market capitalization is roughly $2 million. In the fiscal year ended 2025-12-31, CDT reported $0M in revenue and ($39M) in net income.
CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($37M) | ($15M) | ($5M) | ($3M) |
| Net Income | ($39M) | ($18M) | ($0M) | ($5M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($21M) | ($7M) | ($5M) | ($4M) | ($3M) |
| Net Income | ($21M) | ($7M) | ($6M) | ($5M) | ($2M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $6M | $4M | $7M | $0M | — |
| Total Liabilities | $13M | $11M | $8M | $10M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CDT viewer.
About TickerBase · Data methodology & sources